Company / Return on Equity (ROE)
Pfizer Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
9.0%
FY2025
5-year range
9.0% / 24.7%
FY2021-FY2025
Trend
-1.3%
vs FY2024
Sector context
#38 of 190
Health Care
What the data says
Pfizer's return on equity (roe) of 9.0% is higher than 80% of companies in the Health Care sector (FY2025). Return on Equity (ROE) has fluctuated over the past 10 years, ranging from 9.0% in FY2025 to 25.4% in FY2019.
Based on SEC 10-K filings.
9.0% in FY2025 with a 5-year CAGR of -5.5%. Top quartile in the Health Care sector.
Declined from 24.7% to 9.0% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -0.6pp
- 5-Year Change
- -5.5pp
- 10-Year Change
- -
Sector benchmark
+117.9% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 1.3% year-over-year.
- Currently 59.3pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 9.0% | -1.3% |
| FY2024 | 9.1% | -63.1% |
| FY2023 | 24.7% | +158.0% |
| FY2022 | 9.6% | -53.9% |
| FY2021 | 20.8% | +43.4% |
| FY2020 | 14.5% | -42.9% |
| FY2019 | 25.4% | +123.0% |
| FY2018 | 11.4% | +16.6% |
| FY2017 | 9.8% | -36.4% |
| FY2016 | 15.3% | +42.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026